When the architect, the process team and the EMS integrator each number rooms their own way, every deviation investigation starts with a lookup table. Fix one room code on the room data sheet and carry it into drawings, instrument tags, SOPs, records and door signs, with new codes for split rooms and none reused.
A gap marked closed needs evidence someone else can check: a revised drawing and calculation for a design gap, the same test repeated for a performance gap, an effective SOP with training records for a procedural gap. Agree the evidence before the work starts, and have someone other than the fixer sign it.
Three BIM model reviews at about 30, 60 and 90% of detail design work when each has the right people: QA and production for layout and flows, maintenance for services and access, QA and validation for sampling points and test ports. A comment after a review closes becomes a change request.
'Same product, new box' brings new artwork and codes to control, a registration that may need stability data at other climatic conditions, possibly a new pack to qualify, and one more changeover in the weekly plan. Cost the SKU as a small project before a launch date is promised.
ICH Q10 names knowledge management as one of two enablers of the pharmaceutical quality system: a systematic approach to acquiring, analysing, storing and disseminating information about products, processes and components. In a technology transfer, that means handing over the reason behind each parameter, along with the batch record.
An NCR marked 'rectified' has recorded a repair. To close it properly, state the requirement that was broken, contain the item, decide the disposition and name who decided, find the cause and check for the same fault elsewhere, then verify against the original requirement and attach the evidence.
On the road to registration, facility, utility and equipment qualification sits before the registration batches: fix products and markets in the design basis, qualify, make the batches on qualified equipment, run stability and submit. Where process validation and the inspection fall depends on the region and the process. A delay in PQ moves the earliest submission date.
WHO's technology transfer guideline says the acceptance criteria for a successful transfer should be documented in advance in the transfer protocol. It lists what the protocol should include: objective and scope, both units, the team and its responsibilities, phases and timing, acceptance criteria, and a parallel comparison of premises, equipment, materials and methods.
WHO's technology transfer guideline defines the sending unit and the receiving unit as the involved disciplines at an organization, so two plants of one group have both. The sending unit should assess the receiving unit's preparedness; the receiving unit should be able to accommodate the intended production capacity, and its utilities should have sufficient capacity.
A transfer can deliver every document and still fail at the first trial batch. The WHO guideline (TRS 1044, Annex 4) describes a transfer of products, processes and knowledge, with a joint team, on-site or virtual visits at critical phases where possible, and acceptance criteria documented beforehand. In practice that means people travelling with the files.
An assessor reads what stands behind the registration batches. By the time the first one is made, five things should be true at the receiving site: equipment and rooms qualified, analytical procedures transferred, specifications and suppliers approved, the master batch record issued and operators trained. Each needs a signed document behind it.
Dropping the trial batch makes the first batch a receiving site ever produces the one whose stability data goes into the dossier. ICH Q1A(R2) (2003) says the process used for primary stability batches should simulate the production process. Our advice is to run a trial batch first, compare it with the sending unit's data and fix what it shows.